RxDoctor Payments Data

Donald Bias

Family Medicine · Lincolnton, NCNPI 1174517221

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 113 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by Pfizer at 27.5% of the total.

$1,491in general payments, 2019–2025

Across 113 payments — averaging $13.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$409
  • Novo Nordisk$238
  • Lilly USA, LLC$125
  • Amarin Pharma, Inc.$95
  • AbbVie$82
  • Eisai Inc.$80
  • plus $462 from 11 others
$1,178in research payments, 2019–2025

Across 4 payments — averaging $294.55 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1K

What the payments were for

  • Food & beverage$1,491100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,491 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina →

Other family medicine in Lincolnton

See the full list for North Carolina →

Where these figures come from

Is this you, or does something look wrong? →